Cervical intraepithelial neoplasia
Therapeutic area
Reproductive Health
Rare disease
No
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Cervical intraepithelial neoplasia
- Therapeutic area
- Reproductive Health
- cervical intraepithelial neoplasia
- Cervical Intraepithelial Neoplasm
- Cervical Intraepithelial Neoplasms
- Intraepithelial Neoplasia, Cervical
- Intraepithelial Neoplasm, Cervical
- Intraepithelial Neoplasms, Cervical
- NEOPL CERVICAL INTRAEPITHELIAL
- Neoplasia, Cervical Intraepithelial
- Neoplasm, Cervical Intraepithelial
- Neoplasms, Cervical Intraepithelial
- All therapeutic areas
- Reproductive Health
- Severity
- Unknown
- MONDO ID
- MONDO:0022394
- Parent condition
- MONDO:0006736
Related records
Broader conditions (5)
- Disease
- Disease by body system or component
- Dysplasia of cervix
- Human disease
- Reproductive system disorder
Narrower conditions (2)
Trials (167)
- A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
- A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions
- A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening
- A Efficacy and Safety Study of Composite Gel Containing Black Raspberry Extract in Removing HPV From Patients With Cervical Intraepithelial Neoplasia(CIN) After Cervical Conization
- A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study
- A Multicenter Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening
- A Novel, Low-Cost, Handheld 3D Imaging System for Improved Screening for Cervical Neoplasia in Resource-Limited Settings
- A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
- A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia
- A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects
- A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia
- A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection
- A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
- A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
- A Trial for Patients With Advanced/Recurrent Cervical Cancer
- A Trial of Two Electrosurgical Conizations: Histopathological Analysis of Excision Margins
- A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)
- Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia
- Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)
- Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia
Drugs in development (11)
- Bizalimogene ralaplasmid Phase 3
- Curcumin Phase 1
- Hexaminolevulinate Phase 2
- Human papillomavirus, L1 protein virus like particles Phase 3
- Imiquimod Phase 3
- Paclitaxel Phase 2
- Progesterone Phase 2
- Sivifene Phase 2
- Terameprocol Phase 1
- Tipapkinogene sovacivec Phase 2
- Verpasep caltespen Phase 2